# Akebia Therapeutics, Inc. (AKBA): stock price, chart, support and resistance levels

> Source: IndicatorStack, https://indicatorstack.com/chart/AKBA. Updated Nov 20, 2026, 7:50 PM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

## AKBA at the Nov 20, 2026 close

Akebia Therapeutics (AKBA) closed at $0.3855 on Nov 20, 2026, down 8.71% from the prior close of $0.4223, on light volume of 0.6 times its 20-day average. It opened 2.9% lower and held that direction into the close.

AKBA sits 2% of the way up its 52-week range of $0.3612 to $1.73. It trades 46.1% below its 50-day average and 64.3% below its 200-day average. Over the past month the shares are down 31.4%. A typical day moves about 20.3% from high to low.

LiveChart’s stack bias on the 5-minute chart shows no clear direction. Compass, which reads the higher timeframes, has 0 of 2 timeframes up and 2 down. On the daily chart the bias turned bearish on Aug 12, 2026 at $0.8932, and price has moved −56.8% since.

Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases.

## Key numbers

|  |  |
| --- | --- |
| Previous close | $0.4223 |
| Open | $0.4100 |
| Day range | $0.3849 to $0.4331 |
| 52-week range | $0.3612 to $1.73 |
| Volume | 4.57M (0.6× average) |
| 50-day average | $0.7155 |
| 200-day average | $1.08 |
| Average daily range | 20.3% |
| Average volume (20 days) | 7.47M |
| 1-week change | −18.7% |
| 1-month change | −31.4% |
| 3-month change | −57.2% |
| Market cap | $132M |
| Float | 273M shares |
| Sector | Healthcare |
| Industry | Biotechnology |

## AKBA support and resistance levels

For the next session, measured from the Nov 20, 2026 close of $0.3855: resistance above, support below, nearest first.

| Side | Level | Price | From the close |
| --- | --- | --- | --- |
| Resistance | Prior session low | $0.3964 | +2.8% |
| Resistance | Midpoint on Nov 20 | $0.4090 | +6.1% |
| Resistance | 20-bar high, 5-minute | $0.4125 | +7.0% |
| Resistance | High on Nov 20 | $0.4331 | +12.3% |
| Resistance | 20-day average | $0.5580 | +44.7% |
| Support | Low on Nov 20 | $0.3849 | −0.2% |
| Support | 52-week low | $0.3612 | −6.3% |

## AKBA technical analysis: the stack’s read

As of Nov 20, 2026, 7:50 PM ET.

- Stack bias: No clear bias, waiting for agreement
  - Bigger picture (15m to daily): down
  - VWAP and SMA: neutral
  - Flow: up
  - Momentum: up
  - Trend strength: neutral
- Compass (higher timeframes): 15m and 1h down (15m ↘  1h ↓  2h ↓  4h ↓  D ↓). Below VWAP 0.4030 · above trend SMA · pressing yesterday’s low
- Yesterday’s high: $0.4332 (+12.4% from the close)
- Yesterday’s midpoint: $0.4148 (+7.6% from the close)
- Yesterday’s low: $0.3964 (+2.8% from the close)
- 20-bar resistance: $0.4125 (+7.0% from the close)
- 20-bar support: $0.3855 (+0.0% from the close)

AKBA technical analysis for Nov 20, 2026 (close $0.3855; 5-minute read as of 7:50 PM ET): LiveChart’s 5-minute stack bias has no clear direction, Compass reads “15m and 1h down” across the 15-minute to daily charts, and the daily stack bias has been bearish since Aug 12, 2026. On the daily chart, RSI (14) is 32.7, falling (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads buyers lead: no large size yet; Coil reads flat: no momentum either way; Tripwire has shorts graded Avoid: volume fading into the entry.

## AKBA trend by timeframe

| Timeframe | Direction |
| --- | --- |
| 15-minute | Leaning down |
| 1-hour | Down |
| 2-hour | Down |
| 4-hour | Down |
| Daily | Down |

## AKBA order flow, momentum and trap risk

LiveChart’s Undertow, Coil and Tripwire on the 5-minute chart as of 7:50 PM ET, then the same three on the daily chart at the close.

- **Undertow (order flow)**: Buyers lead: no large size yet
  - Volume: 0.2x this session’s norm · thin, size down
  - Flow: Net buying 12% over 20 bars
  - Tape: No large orders or stacking
- **Coil (momentum)**: Flat: no momentum either way
  - Momentum: RSI 52 above 50, rising · no squeeze
  - MACD: Above its signal, fading
- **Tripwire (trap risk)**: Shorts graded Avoid: volume fading into the entry
  - Longs graded Clean: nothing major in the way
  - Levels: Resistance 0.4125 · support 0.3855
- **Undertow, daily chart**: Selling drying up: price lower, flow higher
- **Coil, daily chart**: Stretched: price lower, RSI higher
- **Tripwire, daily chart**: Shorts graded Avoid: sitting right on support at 0.3612

## AKBA technical indicators

Daily readings at the Nov 20, 2026 close; 5-minute readings as of 7:50 PM ET.

| Indicator | Value | Reading |
| --- | --- | --- |
| RSI (14), daily | 32.7 | Below 50, falling |
| RSI (14), 5-minute | 52.2 | Above 50, rising |
| Squeeze, daily | Off | Bollinger Bands outside the Keltner Channel |
| Squeeze, 5-minute | Off | Bollinger Bands outside the Keltner Channel |
| MACD, daily | Below its signal |  |
| MACD, 5-minute | Above its signal |  |
| VWAP, last 5-minute bar | $0.4030 | Price 1.0% below |
| Fast and slow EMA, 5-minute | $0.3989 and $0.3965 | Fast over slow |
| 20-day average | $0.5580 | Price 30.9% below |
| 50-day average | $0.7155 | Price 46.1% below |
| 200-day average | $1.08 | Price 64.3% below |
| Average daily range (ATR 14) | 20.3% | Of the price |
| Volume against its 20-day average | 0.6× | 4.57M shares |

## AKBA trend history: when the daily bias turned

| Turned | Bias | Price | Held | Move while it held |
| --- | --- | --- | --- | --- |
| Aug 12, 2026 | Bearish | $0.8932 | Holding, 72 sessions | −56.8% |
| Aug 10, 2026 | No clear bias | $0.8440 | 2 sessions | +5.8% |
| Jul 2, 2026 | Bullish | $1.24 | 26 sessions | −31.9% |
| Jun 30, 2026 | No clear bias | $1.14 | 2 sessions | +8.8% |
| May 13, 2026 | Bearish | $1.18 | 32 sessions | −3.4% |
| Mar 17, 2026 | No clear bias | $1.49 | 40 sessions | −20.8% |
| Oct 31, 2025 | Bearish | $2.21 | 92 sessions | −32.6% |
| Oct 22, 2025 | No clear bias | $2.99 | 7 sessions | −26.1% |
| Aug 14, 2025 | Bearish | $3.29 | 48 sessions | −9.1% |
| Aug 11, 2025 | No clear bias | $3.35 | 3 sessions | −1.8% |
| Apr 28, 2025 | Bullish | $2.43 | 72 sessions | +37.9% |
| Apr 2, 2025 | No clear bias | $1.93 | 17 sessions | +25.9% |

Past readings don’t predict future results.

## AKBA daily read log

| Date | Close | Change | Stack bias | Compass | Daily RSI |
| --- | --- | --- | --- | --- | --- |
| Nov 20, 2026 | $0.3855 | −8.71% | No clear bias | 15m and 1h down | 32.7 |
| Nov 13, 2026 | $0.4742 | −4.78% | No clear bias | Tailwind down | – |

## AKBA stock: common questions

### What are AKBA’s support and resistance levels?

Measured from the Nov 20, 2026 close of $0.3855, the nearest resistance is the prior session low at $0.3964 (+2.8%) and the nearest support is the low on Nov 20 at $0.3849 (−0.2%). The full list for the next session is on this page.

### What is the technical analysis for AKBA?

AKBA technical analysis for Nov 20, 2026 (close $0.3855; 5-minute read as of 7:50 PM ET): LiveChart’s 5-minute stack bias has no clear direction, Compass reads “15m and 1h down” across the 15-minute to daily charts, and the daily stack bias has been bearish since Aug 12, 2026. On the daily chart, RSI (14) is 32.7, falling (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads buyers lead: no large size yet; Coil reads flat: no momentum either way; Tripwire has shorts graded Avoid: volume fading into the entry.

### Is AKBA overbought or oversold?

At the Nov 20, 2026 close, AKBA’s daily RSI (14) was 32.7, falling (below 50). On the 5-minute chart, as of 7:50 PM ET, it was 52.2, rising (above 50). Overbought here means 70 or over, oversold 30 or under; neither forecasts a turn.

### What is the trend for AKBA on the 1-hour, 4-hour and daily charts?

As Compass read it at the Nov 20, 2026 close: 15-minute leaning down, 1-hour down, 2-hour down, 4-hour down, Daily down. Overall, Compass reads “15m and 1h down”.

### Is AKBA in a squeeze?

At the Nov 20, 2026 close the squeeze (Bollinger Bands inside the Keltner Channel) was off on the daily chart and off on the 5-minute chart (as of 7:50 PM ET). Coil, LiveChart’s momentum layer, boxes every squeeze on the chart and marks its release.

### Are buyers or sellers in control of AKBA?

As of 7:50 PM ET on Nov 20, 2026, Undertow, LiveChart’s order flow layer, read buyers lead: no large size yet on the 5-minute chart (volume: 0.2x this session’s norm · thin, size down; flow: Net buying 12% over 20 bars; tape: No large orders or stacking).

### Is AKBA at risk of a bull or bear trap?

As of 7:50 PM ET on Nov 20, 2026, Tripwire, LiveChart’s trap check, had shorts graded Avoid: volume fading into the entry on the 5-minute chart; longs graded Clean: nothing major in the way; levels: Resistance 0.4125 · support 0.3855. Its grades describe the structure around price; they aren’t a call on direction.

### What is Akebia Therapeutics’s stock price?

AKBA closed at $0.3855 on Nov 20, 2026, −8.71% on the day. The chart at the top of this page shows the latest price while the market is open.

### Is AKBA bullish or bearish right now?

As of the Nov 20, 2026 close the stack bias is no clear bias, with 2 of its 5 reads pointing up. On the daily chart it is bearish. Compass reads “15m and 1h down” across the 15-minute to daily timeframes. This describes the trend at the last close; it isn’t a forecast.

### Is AKBA above its 50-day and 200-day moving averages?

At the Nov 20, 2026 close of $0.3855, AKBA was 46.1% below its 50-day moving average ($0.7155) and 64.3% below its 200-day moving average ($1.08).

### What is AKBA’s 52-week high and low?

Over the past year AKBA has traded between $0.3612 and $1.73, and it closed 2% of the way up that range.

### How much does AKBA move in a day?

Over the last 14 sessions its average daily range (average true range) was 20.3% of its price, about $0.0783 a share.

### What is AKBA’s average volume?

AKBA averaged 7.47M shares a day over the 20 sessions before Nov 20, 2026. That day it traded 4.57M, 0.6 times that average.

### How has AKBA stock performed recently?

Measured to the Nov 20, 2026 close, AKBA is down 18.7% over the past week, down 31.4% over the past month and down 57.2% over the past three months.

### Did AKBA gap down on Nov 20, 2026?

Yes. It opened at $0.4100, 2.9% below the prior close of $0.4223, and closed at $0.3855 (−8.71%).

### How many shares of AKBA are in the float?

About 273M shares.

### What is Akebia Therapeutics’s market cap?

About $132M, from its latest company profile. It is in the Healthcare sector (Biotechnology).

### What is the outlook for AKBA stock?

This page doesn’t forecast prices. It shows where AKBA stands: the stack bias is no clear bias, the nearest resistance is $0.3964, the nearest support is $0.3849, and the live chart above shows how price is reacting to those levels.

## Other Healthcare stocks

- SLS (+156.8%): https://indicatorstack.com/chart/SLS
- MEDS (+84.1%): https://indicatorstack.com/chart/MEDS
- CUE (+68.2%): https://indicatorstack.com/chart/CUE
- MRKR (+54.7%): https://indicatorstack.com/chart/MRKR
- APRE (−53.6%): https://indicatorstack.com/chart/APRE
- SCLX (−48.6%): https://indicatorstack.com/chart/SCLX
- AYTU (+46.2%): https://indicatorstack.com/chart/AYTU
- MIRA (−37.7%): https://indicatorstack.com/chart/MIRA
- SNTI (−36.6%): https://indicatorstack.com/chart/SNTI
- KYNB (−36.3%): https://indicatorstack.com/chart/KYNB

Live chart with the stack’s read on every bar: https://indicatorstack.com/chart/AKBA

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
